India now prime destination for big pharma's global clinical trials
India's clinical trials market is expected to reach $3.15 billion by 2025 with a compounded annual growth rate of 8.7%.
vaccine development
February 2022
December 2021
Covid-19 put spotlight on vaccines, diagnostics: Mazumdar-Shaw
Resurgence of interest and new technologies bring a huge opportunity for the vaccine development field, says Biocon CMD Kiran Mazumdar-Shaw.
Predictions 2022: India to consolidate in vaccine-making for the world, says Bharat Biotech's Krishna Ella
The advancement of science in the year to come will be influenced significantly by the government's academic policies, writes Bharat Biotech CMD Krishna Ella.
